Literature DB >> 27186274

MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.

Yonggang Zhu1, Hongguang Zhao2, Li Feng1, Songbai Xu3.   

Abstract

MircroRNA-217 (miR-217) has been showed to involve in the initiation and development of human cancers, and is recognize as a tumor suppressor miRNA in several tumors. However, the clinical significance and its underlying role in human glioma remain unclear. Herein, we found that the expression of miR-217 was significantly down-regulated in glioma tissues as compared with adjacent normal brain tissues. Clinical association analysis disclosed that low-expression of miR-217 was evidently negative associated with advanced tumor stage (grade III + IV) in glioma. Further function assays showed that miR-217 inhibited proliferation, colony formation, invasion and migration of glioma cells. Notably, runt-related transcription factors 2 (Runx2) was identified as a functional target of miR-217 in glioma. Furthermore, an inverse correlation between miR-217 and Runx2 expression was observed in glioma tissues. Downregulation of Runx2 has similar with inhibition effect of overexpression of miR-217, and upregulation of Runx2 reversed the effects of overexpressing of miR-217. Taken together, these results suggest a critical role of miR-217 in suppressing proliferation, migration, and invasion of glioma by targeting Runx2.

Entities:  

Keywords:  Glioma; Runx2; invasion; miR-217; proliferation

Year:  2016        PMID: 27186274      PMCID: PMC4859633     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

Review 1.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

2.  The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.

Authors:  Wu-Gan Zhao; Shuang-Ni Yu; Zhao-Hui Lu; Yi-Hui Ma; Yu-Mei Gu; Jie Chen
Journal:  Carcinogenesis       Date:  2010-07-30       Impact factor: 4.944

Review 3.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

4.  Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme.

Authors:  Michael Karsy; Erol Arslan; Fred Moy
Journal:  Genes Cancer       Date:  2012-01

Review 5.  Epidemiology of brain tumors.

Authors:  Hiroko Ohgaki
Journal:  Methods Mol Biol       Date:  2009

Review 6.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 7.  MicroRNAs in cell proliferation, cell death, and tumorigenesis.

Authors:  H-W Hwang; J T Mendell
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

8.  MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.

Authors:  Qiang Zhang; Yonghui Yuan; Jianchun Cui; Tingting Xiao; Daqing Jiang
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

9.  MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.

Authors:  Bo Wang; Zhan-Long Shen; Ke-Wei Jiang; Gang Zhao; Chun-You Wang; Yi-Chao Yan; Yang Yang; Ji-Zhun Zhang; Chao Shen; Zhi-Dong Gao; Ying-Jiang Ye; Shan Wang
Journal:  BMC Cancer       Date:  2015-05-28       Impact factor: 4.430

Review 10.  Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation.

Authors:  Ayla Valinezhad Orang; Reza Safaralizadeh; Mina Kazemzadeh-Bavili
Journal:  Int J Genomics       Date:  2014-08-10       Impact factor: 2.326

View more
  16 in total

1.  miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma.

Authors:  Atreye Majumdar; Fahim Ahmad; Touseef Sheikh; Reshma Bhagat; Pankaj Pathak; Shanker Datt Joshi; Pankaj Seth; Vivek Tandon; Manjari Tripathi; P Saratchandra; Chitra Sarkar; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2017-08-25       Impact factor: 4.599

2.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  miR-217-5p induces apoptosis by directly targeting PRKCI, BAG3, ITGAV and MAPK1 in colorectal cancer cells.

Authors:  Marion Flum; Michael Kleemann; Helga Schneider; Benjamin Weis; Simon Fischer; René Handrick; Kerstin Otte
Journal:  J Cell Commun Signal       Date:  2017-09-14       Impact factor: 5.782

5.  Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression.

Authors:  Ping Ouyang; Kun Wu; Liudan Su; Weifang An; Yanhong Bie; He Zhang; Haixian Kang; Enping Jiang; Wei Zhu; Yunhong Yao; Xinrong Hu; Zhangquan Chen; Sen Wang
Journal:  Ann Transl Med       Date:  2019-10

6.  miR-543 functions as a tumor suppressor in glioma in vitro and in vivo.

Authors:  Liang Xu; Ju Yu; Zhongyong Wang; Qing Zhu; Wenjie Wang; Qing Lan
Journal:  Oncol Rep       Date:  2017-06-12       Impact factor: 3.906

7.  MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.

Authors:  Yuanlong Xie; Wenchao Sun; Zhouming Deng; Xiaobin Zhu; Chao Hu; Lin Cai
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

8.  Polymorphisms of rs1347093 and rs1397529 are associated with lung cancer risk in northeast Chinese population.

Authors:  Xiaoying Li; XueLian Li; Yangwu Ren; Zhihua Yin; Xiaowei Quan; Xiaoxia Xue; Baosen Zhou
Journal:  Oncotarget       Date:  2017-10-24

9.  miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.

Authors:  Wenhui Zhou; Fangfang Song; Qiuju Wu; Rong Liu; Lulu Wang; Cuicui Liu; You Peng; Shuqin Mao; Jing Feng; Ceshi Chen
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

10.  Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration.

Authors:  Jia-Jian Wang; Kun Shan; Bai-Hui Liu; Chang Liu; Rong-Mei Zhou; Xiu-Miao Li; Rui Dong; Shu-Jie Zhang; Sheng-Hai Zhang; Ji-Hong Wu; Biao Yan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.